Kindstar Globalgene Technology
Kindstar Globalgene Technology, headquartered in China, is a leading player in the biotechnology industry, specialising in genetic testing and precision medicine. Founded in 2014, the company has rapidly expanded its operations across major regions in Asia, establishing a strong presence in the healthcare sector. The firm is renowned for its innovative core services, including comprehensive genomic testing and advanced diagnostic solutions, which are distinguished by their accuracy and reliability. Kindstar's commitment to research and development has positioned it as a pioneer in the field, contributing significantly to personalised healthcare. With a focus on enhancing patient outcomes, Kindstar Globalgene Technology has achieved notable milestones, including partnerships with various healthcare institutions and a growing portfolio of patented technologies. This strategic approach has solidified its market position as a trusted provider of genetic testing services in the region.
DitchCarbon Score
How does Kindstar Globalgene Technology's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Kindstar Globalgene Technology's score of 26 is higher than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Kindstar Globalgene Technology's reported carbon emissions
In 2023, Kindstar Globalgene Technology reported total carbon emissions of approximately 4,160,550 kg CO2e. This figure includes about 277,450 kg CO2e from Scope 1 emissions and approximately 3,883,100 kg CO2e from Scope 2 emissions. The company has shown a slight increase in emissions compared to 2022, where total emissions were about 3,581,090 kg CO2e, with Scope 1 emissions at approximately 103,420 kg CO2e and Scope 2 emissions at around 3,477,670 kg CO2e. In 2021, Kindstar's total emissions were about 4,070,250 kg CO2e, with Scope 1 emissions of approximately 28,810 kg CO2e and Scope 2 emissions of about 91,770 kg CO2e. Notably, there were no reported Scope 3 emissions in any of the years disclosed. Despite the fluctuations in emissions, Kindstar has not publicly committed to specific reduction targets or initiatives, as indicated by the absence of documented reduction targets or climate pledges. The company continues to monitor its emissions, with an average GHG emissions intensity of approximately 1,330 kg CO2e per employee in 2023. Overall, while Kindstar Globalgene Technology has made strides in tracking its carbon footprint, further commitments to emissions reduction would enhance its climate strategy.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 28,810 | 000,000 | 000,000 |
| Scope 2 | 91,770 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Kindstar Globalgene Technology is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
